Evaluation of Clinical Interest of Anti-Aquaporin-4 Autoantibody Followup in Neuromyelitis Optica
Open Access
- 28 April 2013
- journal article
- research article
- Published by Hindawi Limited in Journal of Immunology Research
- Vol. 2013, 1-7
Abstract
Neuromyelitis optica (NMO) is an autoimmune disease in which a specific biomarker named NMO-IgG and directed against aquaporin-4 (AQP4) has been found. A correlation between disease activity and anti-AQP4 antibody (Ab) serum concentration or complement-mediated cytotoxicity has been reported, but the usefulness of longitudinal evaluation of these parameters remains to be evaluated in actual clinical practice. Thirty serum samples from 10 NMO patients positive for NMO-IgG were collected from 2006 to 2011. Anti-AQP4 Ab serum concentration and complement-mediated cytotoxicity were measured by flow cytometry using two quantitative cell-based assays (CBA) and compared with clinical parameters. We found a strong correlation between serum anti-AQP4 Ab concentration and complement-mediated cytotoxicity (). Nevertheless, neither relapse nor worsening of impairment level was closely associated with a significant increase in serum Ab concentration or cytotoxicity. These results suggest that complement-mediated serum cytotoxicity assessment does not provide extra insight compared to anti-AQP4 Ab serum concentration. Furthermore, none of these parameters appears closely related to disease activity and/or severity. Therefore, in clinical practice, serum anti-AQP4 reactivity seems not helpful as a predictive biomarker in the followup of NMO patients as a means of predicting the onset of a relapse and adapting the treatment accordingly.
Keywords
Funding Information
- CHU de Montpellier
This publication has 28 references indexed in Scilit:
- Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patientsJournal of Neuroinflammation, 2012
- Aquaporin-4 Antibodies in Neuromyelitis Optica and Longitudinally Extensive Transverse MyelitisArchives of Neurology, 2008
- NMO-IgG predicts the outcome of recurrent optic neuritisNeurology, 2008
- The spectrum of neuromyelitis opticaThe Lancet Neurology, 2007
- Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titreBrain, 2007
- Revised diagnostic criteria for neuromyelitis opticaNeurology, 2006
- Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitisAnnals of Neurology, 2006
- IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channelJournal of Experimental Medicine, 2005
- A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosisThe Lancet, 2004
- A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis opticaBrain, 2002